Evidence map›Paper›PMID 25004450›Full record

ArticlePLoS biology2014

An immunological marker of tolerance to infection in wild rodents.

Joseph A Jackson, Amy J Hall, Ida M Friberg, Catriona Ralli, Ann Lowe, Malgorzata Zawadzka, Andrew K Turner, Alexander Stewart, Richard J Birtles, Steve Paterson and 2 more

Abstract read
In one paragraph

Article in PLoS biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Article
  3. Parasitology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Coevolution of Age-Structured Tolerance and Virulence.Bulletin of mathematical biology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Amphibian infection tolerance to chytridiomycosis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Ecological Analysis of the Helminth Community ofAnimals : an open access journal from MDPI · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joseph A JacksonIBERS, Aberystwyth University, Aberystwyth, United Kingdom.
Amy J HallSchool of Life Sciences, The University of Nottingham, Nottingham, United Kingdom.
Ida M FribergSchool of Life Sciences, The University of Nottingham, Nottingham, United Kingdom; Institute of Integrative Biology, The University of Liverpool, Liverpool, United Kingdom.
Catriona RalliSchool of Life Sciences, The University of Nottingham, Nottingham, United Kingdom.
Ann LoweSchool of Life Sciences, The University of Nottingham, Nottingham, United Kingdom.
Malgorzata ZawadzkaInstitute of Integrative Biology, The University of Liverpool, Liverpool, United Kingdom.
Andrew K TurnerInstitute of Integrative Biology, The University of Liverpool, Liverpool, United Kingdom.
Alexander StewartIBERS, Aberystwyth University, Aberystwyth, United Kingdom.
Richard J BirtlesSchool of Environment and Life Sciences, University of Salford, Salford, United Kingdom.
Steve PatersonInstitute of Integrative Biology, The University of Liverpool, Liverpool, United Kingdom.
Janette E BradleySchool of Life Sciences, The University of Nottingham, Nottingham, United Kingdom.
Mike BegonInstitute of Integrative Biology, The University of Liverpool, Liverpool, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hosts are likely to respond to parasitic infections by a combination of resistance (expulsion of pathogens) and tolerance (active mitigation of pathology). Of these strategies, the basis of tolerance in animal hosts is relatively poorly understood, with especially little known about how tolerance is manifested in natural populations. We monitored a natural population of field voles using longitudinal and cross-sectional sampling modes and taking measurements on body condition, infection, immune gene expression, and survival. Using analyses stratified by life history stage, we demonstrate a pattern of tolerance to macroparasites in mature compared to immature males. In comparison to immature males, mature males resisted infection less and instead increased investment in body condition in response to accumulating burdens, but at the expense of reduced reproductive effort. We identified expression of the transcription factor Gata3 (a mediator of Th2 immunity) as an immunological biomarker of this tolerance response. Time series data for individual animals suggested that macroparasite infections gave rise to increased expression of Gata3, which gave rise to improved body condition and enhanced survival as hosts aged. These findings provide a clear and unexpected insight into tolerance responses (and their life history sequelae) in a natural vertebrate population. The demonstration that such responses (potentially promoting parasite transmission) can move from resistance to tolerance through the course of an individual's lifetime emphasises the need to incorporate them into our understanding of the dynamics and risk of infection in the natural environment. Moreover, the identification of Gata3 as a marker of tolerance to macroparasites raises important new questions regarding the role of Th2 immunity and the mechanistic nature of the tolerance response itself. A more manipulative, experimental approach is likely to be valuable in elaborating this further.

Indexed as

AnimalsAnimals, WildArvicolinaeCross-Sectional StudiesGATA3 Transcription FactorHost-Parasite InteractionsImmune ToleranceLongitudinal StudiesMaleParasitic DiseasesGATA3 Transcription Factor

Identifiers

PMID25004450
PMCPMC4086718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.